Literature DB >> 14563372

Phosphatases in concert with kinases set the gain for signal transduction through the T cell receptor.

Andrew E Schade1, Alan D Levine.   

Abstract

The 'tunable activation thresholds' model for signal transduction through the T cell receptor (TCR)/CD3 signaling complex proposes that rapid cycles of phosphorylation and dephosphorylation are integral to regulating the frequency of protein-protein interaction, thus having considerable influence over the activation of downstream signaling pathways. Co-temporal activation of kinases and phosphatases could serve to modulate the ongoing signaling response, depending on the relative balance of their opposing enzymatic activities. Although recent reports have addressed the mechanisms by which specific kinase/phosphatase pairs contribute to the initiation and termination of signaling, we sought a more global understanding of the ability of the kinase/phosphatase balance to regulate, or "tune", the very proximal steps of TCR signaling in primary human T cells. Herein, we provide biochemical evidence that phosphotyrosine induction via the TCR is subject to fine-tuning based on the overall activity of kinases and phosphatases relative to one another, leading to cycles of phosphorylation and dephosphorylation, with implications for developing the next generation of immunotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563372     DOI: 10.1016/s0161-5890(03)00170-6

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

1.  Vitamin E reverses impaired linker for activation of T cells activation in T cells from aged C57BL/6 mice.

Authors:  Melissa G Marko; Hoan-Jen E Pang; Zhihong Ren; Angelo Azzi; Brigitte T Huber; Stephen C Bunnell; Simin Nikbin Meydani
Journal:  J Nutr       Date:  2009-04-29       Impact factor: 4.798

2.  Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.

Authors:  Andrew E Schade; Gary L Schieven; Robert Townsend; Anna M Jankowska; Vojkan Susulic; Rosemary Zhang; Hadrian Szpurka; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2007-10-25       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.